| Market Cap | 36.96B | P/E | 25.42 | EPS this Y | 2.50% | Ern Qtrly Grth | 2.90% |
| Income | 2.74B | Forward P/E | 10.11 | EPS next Y | 11.20% | 50D Avg Chg | 1.00% |
| Sales | 142.8B | PEG | 0.91 | EPS past 5Y | 7.05% | 200D Avg Chg | -7.00% |
| Dividend | N/A | Price/Book | 1.43 | EPS next 5Y | 12.51% | 52W High Chg | -32.00% |
| Recommedations | 2.30 | Quick Ratio | 1.11 | Shares Outstanding | 533.66M | 52W Low Chg | 10.00% |
| Insider Own | 0.29% | ROA | 3.67% | Shares Float | 531.27M | Beta | 0.41 |
| Inst Own | 98.40% | ROE | 10.44% | Shares Shorted/Prior | 7.59M/9.60M | Price | 67.35 |
| Gross Margin | 15.69% | Profit Margin | 1.92% | Avg. Volume | 3,252,025 | Target Price | 89.40 |
| Oper. Margin | 4.39% | Earnings Date | Jul 26 | Volume | 3,074,085 | Change | -0.97% |
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
| Barclays | Overweight | May 2, 24 |
| Deutsche Bank | Hold | Apr 30, 24 |
| Oppenheimer | Outperform | Apr 29, 24 |
| Wells Fargo | Overweight | Apr 15, 24 |
| Wells Fargo | Overweight | Apr 8, 24 |
| Cantor Fitzgerald | Overweight | Apr 4, 24 |
| Stephens & Co. | Equal-Weight | Mar 25, 24 |
| Stephens& Co. | Equal-Weight | Mar 21, 24 |
| Wells Fargo | Overweight | Mar 20, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Robinson Lori Jean | Director Director | Apr 27 | Sell | 66.59 | 1,400 | 93,226 | 8,508 | 04/28/23 |
| Asher Andrew Lynn | EVP, CFO EVP, CFO | Feb 09 | Buy | 71.93 | 6,800 | 489,124 | 314,755 | 02/10/23 |
| BAGLEY SHANNON | EVP, Chief Admin. Of.. EVP, Chief Admin. Officer | Jul 29 | Sell | 92.21 | 9,000 | 829,890 | 118,194 | 08/01/22 |
| Robinson Lori Jean | Director Director | Jul 28 | Sell | 92.77 | 1,200 | 111,324 | 9,908 | 08/01/22 |
| GEPHARDT Richard A | Director Director | Jul 08 | Sell | 88 | 4,480 | 394,240 | 22,560 | 07/12/22 |
| GEPHARDT Richard A | Director Director | Jun 21 | Sell | 82.02 | 13,520 | 1,108,910 | 27,040 | 06/23/22 |
| BAGLEY SHANNON | EVP, Chief Admin. Of.. EVP, Chief Admin. Officer | Apr 29 | Sell | 80.99 | 8,000 | 647,920 | 128,353 | 05/03/22 |
| COUGHLIN CHRISTOPHER J | Director Director | Apr 29 | Buy | 81.37 | 12,000 | 976,440 | 15,865 | 05/03/22 |
| Dallas H James | Director Director | Apr 29 | Buy | 81.75 | 3,065 | 250,564 | 32,582 | 05/03/22 |
| Samuels Theodore R. II | Director Director | Apr 28 | Buy | 80.94 | 6,270 | 507,494 | 11,000 | 05/02/22 |
| BROOKS MARK J | EVP, Chief Informati.. EVP, Chief Information Officer | Mar 24 | Sell | 82.71 | 3,690 | 305,200 | 153,755 | 03/28/22 |
| BROOKS MARK J | EVP, Chief Informati.. EVP, Chief Information Officer | Jan 20 | Sell | 80 | 2,774 | 221,920 | 160,422 | 01/24/22 |
| THOMAS DAVID P | EVP, MARKETS EVP, MARKETS | Jan 11 | Sell | 77.61 | 4,000 | 310,440 | 82,253 | 01/11/22 |
| NEIDORFF MICHAEL F | Chairman & CEO Chairman & CEO | Nov 01 | Sell | 79.74 | 50,000 | 3,987,000 | 6,404,073 | 12/14/21 |
| CASSO KATIE | SVP & Corporate Cont.. SVP & Corporate Controller | Dec 10 | Sell | 79.19 | 8,000 | 633,520 | 31,977 | 12/14/21 |
| ROBERTS JOHN R | Director Director | Nov 04 | Sell | 75.04 | 20,000 | 1,500,800 | 194,465 | 11/12/21 |
| LAYTON BRENT D | President & COO President & COO | Oct 28 | Sell | 70.41 | 4,000 | 281,640 | 530,204 | 11/01/21 |
| ROBERTS JOHN R | Director Director | May 11 | Sell | 70 | 5,000 | 350,000 | 8,879 | 05/11/21 |
| NEIDORFF MICHAEL F | Chairman, President.. Chairman, President & CEO | Nov 10 | Sell | 70.12 | 300,000 | 21,036,000 | 6,287,732 | 11/10/20 |
| Hunter Jesse N | EVP, M&A & Chief Str.. EVP, M&A & Chief Strategy Ofcr | Nov 10 | Sell | 70 | 22,500 | 1,575,000 | 378,029 | 11/10/20 |
| Thompson Tommy G | Director Director | Oct 02 | Sell | 58.36 | 1,500 | 87,540 | 160,896 | 10/02/20 |